Buying at Atrium
When markets pull back, investors often look to the defensive consumer staples area for cover. Today we look at Atrium Innovations Inc., (yesterday's close $11.97). Not only did the health and nutrition foods stock perform well versus the S&P/TSX composite index during the recent market selloff, but on July 8, CEO Pierre Fitzgibbon acquired 8,500 shares at prices between $11.90 and $12.
Also, over the past year, officers and directors (including the CEO) as a group bought just over $500,000 of stock in the market. CFO Mario Paradis acquired 8,000 shares at an average price of $13.69. Meanwhile, during the last three months, 10-per-cent holder Fonds de solidarité FTQ bought 450,000 shares privately at prices ranging between $12 and $12.99 (not shown on chart).
Ted Dixon is CEO of INK Research which provides insider news and knowledge to investors about Canadian markets. INK employees or directors may hold shares in investments profiled. Securities referenced in this profile may have already appeared in recent reports distributed to INK Research clients.
© The Globe and Mail
Only GlobeinvestorGOLD combines the strength of powerful investing tools with the insight of The Globe and Mail.
Discover a wealth of investment information and and exclusive features.
